Home » Stocks » BTHE

Boston Therapeutics Inc. (BTHE)

Stock Price: $0.0068 USD -0.0025 (-26.88%)
Updated December 3, 4:00 PM EST - Market closed

BTHE Stock Price Chart

Key Info

Market Cap 755,693
Revenue (ttm) 15,337
Net Income (ttm) -2.87M
Shares Out 111.13M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $0.0068
Previous Close $0.0093
Change ($) -0.0025
Change (%) -26.88%
Day's Open 0.0093
Day's Range 0.0068 - 0.0100
Day's Volume 0
52-Week Range 0.0000 - 0.0100

BTHE Stock News

There are no news available yet.

About BTHE

Boston Therapeutics, a pre-clinical and clinical-stage pharmaceutical development company, focuses on the development, manufacture, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements in the United States. Its lead pharmaceutical drug candidates are BTI-320, a non-systemic carbohydrate-based compound that is in Phase IIb clinical trial to reduce post-meal elevation of blood glucose levels in Type 2 diabetic and pre diabetic patients; BTI-410, a peptide injectable compound that has completed Phase Ib clinical tr... [Read more...]

Industry
Biotechnology
Founded
2009
Stock Exchange
US OTC
Ticker Symbol
BTHE
Full Company Profile

Financial Performance

In 2019, BTHE's revenue was $16,329, a decrease of -48.53% compared to the previous year's $31,723. Losses were -$3.69 million, 2.58% more than in 2018.

Financial Statements